Four patients with squamous cell carcinoma had molecular abnormalities atypical for this histological type, suggesting a secondary adenocarcinomatous contingent: a KRAS G12C mutation, a KRAS amplification, a STK11 mutation and an ALK mutation. The gene discussed is KRAS; the disease is squamous cell carcinoma.